MergerLinks Header Logo

Request Deal Involvement

Novartis completed the spin-off Sandoz in an $11.4bn deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Brunswick Group

pr advisors

Brunswick Group

Cravath Swaine & Moore

legal advisors

Cravath Swaine & Moore

UBS

financial advisors

UBS

Gordon Dyal & Co

financial advisors

Gordon Dyal & Co

Lenz & Staehelin

legal advisors to financial advisors

Lenz & Staehelin

Bar & Karrer

legal advisors

Bar & Karrer

Bank of America

financial advisors

Bank of America

Rothschild & Co

financial advisors

Rothschild & Co

or

Principals

INSTITUTIONAL INVESTORS

bidder

INSTITUTIONAL INVESTORS

NOVARTIS AG

vendor

NOVARTIS AG

SANDOZ

target

SANDOZ

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novartis completed the spin-off Sandoz in an $11.4bn deal.